Efficacy and Safety Study of Norethindrone Acetate Transdermal Delivery System in Contraception

Clinical trial NCT01140217 · COMPLETED

Trial details

NCT number: NCT01140217
Sponsor: Watson Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Contraceptive Usage

Start date: 2010-05-01
Primary completion: 2012-03-01
Enrollment: 1659

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.